We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

27 hedge funds and large institutions have $8.97M invested in Assembly Biosciences in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more call options, than puts

Call options by funds: $82K | Put options by funds: $29K

55% more capital invested

Capital invested by funds: $5.77M → $8.97M (+$3.19M)

4% less funds holding

Funds holding: 28 → 27 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
7
Closed
7
Calls
$82K
Puts
$29K
Net Calls
+$53K
Net Calls Change
+$62K

Top Buyers

1
Jennison Associates
Jennison Associates
New York
+$2.36M
2
Millennium Management
Millennium Management
New York
+$568K
3
BIT
BlackRock Institutional Trust
California
+$378K
4
GTC
Ghost Tree Capital
New York
+$236K
5
Jane Street
Jane Street
New York
+$111K

Top Sellers

1
BBA
Baker Bros. Advisors
New York
-$535K
2
Deutsche Bank
Deutsche Bank
Germany
-$109K
3
BFA
BlackRock Fund Advisors
California
-$97K
4
Citadel Advisors
Citadel Advisors
Florida
-$90K
5
Renaissance Technologies
Renaissance Technologies
New York
-$86.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$2.62M +$2.36M +33,333 New
VAM
2
Visium Asset Management
New York
$2.36M – – –
BIT
3
BlackRock Institutional Trust
California
$1.72M +$378K +5,331 +32%
Millennium Management
4
Millennium Management
New York
$658K +$568K +8,008 +2,231%
Vanguard Group
5
Vanguard Group
Pennsylvania
$613K +$82.3K +1,160 +17%
GTC
6
Ghost Tree Capital
New York
$262K +$236K +3,333 New
Jane Street
7
Jane Street
New York
$123K +$111K +1,570 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$99K -$71 -1 -0.1%
Goldman Sachs
9
Goldman Sachs
New York
$98K -$36.2K -511 -29%
Renaissance Technologies
10
Renaissance Technologies
New York
$83K -$86.5K -1,220 -54%
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$74K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$59K +$52.8K +745 New
Northern Trust
13
Northern Trust
Illinois
$43K – – –
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$42K +$10.4K +146 +37%
NCCM
15
Nine Chapters Capital Management
New Jersey
$37K +$33.8K +477 New
Group One Trading
16
Group One Trading
Illinois
$22K -$37.8K -533 -66%
Citadel Advisors
17
Citadel Advisors
Florida
$18K -$90K -1,269 -84%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$16K – – –
BA
19
BlackRock Advisors
Delaware
$9K – – –
GSC
20
Ground Swell Capital
South Carolina
$8K +$6.88K +97 New
Morgan Stanley
21
Morgan Stanley
New York
$2K -$36.6K -516 -95%
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$1.55K – – –
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
Wells Fargo
24
Wells Fargo
California
$1K – – –
BBA
25
Baker Bros. Advisors
New York
– -$535K -6,962 Closed
1
2

ASMB Hedge Fund Activity: Q2 2014 in Review

27 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2014, worth a combined $8.97M — up 55% from $5.77M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ASMB and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.

The largest buyer was Jennison Associates, opening a new position worth an estimated $2.36M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $535K sold.

  • 27 institutional investors held Assembly Biosciences (ASMB) as of Q2 2014, down from 28 in Q1 2014.
  • Funds reported $8.97M of Assembly Biosciences stock for Q2 2014, up 55% quarter-over-quarter.
  • 6 funds opened new Assembly Biosciences positions in Q2 2014 and 7 closed out, a net change of -1 holder.
  • The largest Assembly Biosciences buyer in Q2 2014 was Jennison Associates, an estimated $2.36M added.
  • The largest Assembly Biosciences seller in Q2 2014 was Baker Bros. Advisors, an estimated $535K sold.

Based on aggregated 13F filings for Q2 2014.